J Frontier Co Ltd

J Frontier maintains a liquidity position with a current ratio of 1.19 and a cash and equivalents balance of ¥2,169,645,000, but its debt-to-equity ratio of 3.09 indicates a high leverage position. The company's net cash is negative after subtracting total debt, signaling potential liquidity risk. The company's profitability is modest, with a return on equity of 6.23% and a return on assets of 0.95%. These figures are below the typical thresholds for high-performing firms in the retail and healthcare sectors, suggesting that J Frontier may not be generating returns at a level that justifies its capital structure. J Frontier operates through three business segments: Healthcare Sales, Medical Care Sales, and Health Care Marketing. The company's revenue is distributed across these segments, but the input data does not provide specific revenue figures for each segment, making it difficult to assess concentration risk or growth potential within individual business lines. The company's growth trajectory is not explicitly detailed in the input data, but the recent actual revenue of ¥21,504,500,000 suggests a stable revenue base. The absence of forward-looking guidance or detailed growth projections limits the ability to assess future performance. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's capital structure is heavily leveraged, with long-term debt of ¥4,343,824,000, which could pose a challenge in periods of rising interest rates or economic downturns. The dilution risk is low, as the number of shares outstanding is the same for both basic and diluted shares. Recent events and filings are not detailed in the input data, so there is no specific information to reference regarding recent corporate actions or strategic developments. The company's financial snapshot does not include recent filings or transcripts that could provide insight into management's strategy or operational changes.